Imipenem-resistance among multi-drug resistant clinical strains in urinary infections from Kolkata [1]

Indian Journal of Medical Research

Volumn 125, Issue 5, 2007, Pages 689-691

  Arora, Suranjana ^b   Saha, Sanchita ^a   Bal, Manjusri ^a  

^a Shadan Institute of Medical Sciences and Post Graduate Research Centre   (India)

^b UNIVERSITY OF CALCUTTA   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; AZTREONAM; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFALEXIN; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; EDETIC ACID; ERYTHROMYCIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MERCAPTOETHANOL; MEROPENEM; PENICILLIN DERIVATIVE; SULBACTAM; TAZOBACTAM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM ISOLATE; ENZYME SYNTHESIS; GRAM NEGATIVE BACTERIUM; GROWTH INHIBITION; HUMAN; INDIA; KLEBSIELLA PNEUMONIAE; LETTER; MULTIDRUG RESISTANCE; NONHUMAN; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; IMIPENEM; URINARY TRACT INFECTIONS;

EID: 34547512425     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Letter

References (13)

1. Barza M. Imipenem: first of a new class of beta-lactam antibiotics. Ann Intern Med 1985; 103: 522-66.
2. Kurokawa H, Yagi T, Shibata N, Shibayama K, Arakawa Y. Worldwide proliferation of carbapenem-resistant Gram-negative bacteria. Lancet 1999; 354: 955.
3. Lee K, Lim YS, Yong D, Yum JH, Chong Y. Evaluation of the Hodge test and imipenem-EDTA double-disk synergy test for differentiating metallo-beta-lactamase-producing isolates of Pseudomonas spp. And Acinetobacter spp. J Clin Microbiol 2003; 41: 4623-9.
4. Koh TH, Babini GS, Woodford N, Sng LH, Hall LM, Livermore DM. Carbapenem hydrolyzing IMP-1 beta-lactamase in Klebsiella pneumoniae from Singapore. Lancet 1999; 353: 2162.
5. Takeyama K, Kunishima Y, Matsukawa M, Takahashi S, Hirose T, Kobayashi N, et al. Multi-drug resistant Pseudomonas aeruginosa isolated from the urine of patients with urinary tract infection. J Infect Chemotherapy 2002; 8: 59-63.
6. Navaneeth BV, Sridharan D, Sahay D, Belwadi MRS. A preliminary study on metallo-beta-lactamase producing Pseudomonas aeruginosa in hospitalized patients. Indian J Med Res 2002; 116: 264-7.
7. Mendiratta DK, Deotale V, Narang P. Metallo-beta-lactamase producing Pseudomonas aeruginosa in a hospital from a rural area. Indian J Med Res 2005; 121: 701-3.
8. Jesudason MV, Kandathil AJ, Balaji V. Comparison of two methods to detect carbapenemase & metallo-beta-lactamase production in clinical isolates. Indian J Med Res 2005; 121: 780-3.
9. Hemlatha-V, Sekar U, Kamat V. Detection of metallo-beta-lactamase producing Pseudomonas aeruginosa in hospitalized patients. Indian J Med Res 2005; 122: 148-52.
10. Ray B, Panja K, Bal M. In vitro activity of N-forthimidodoyl thienamycin (MK 0787) compared, with other beta-lactamase stable cephalosporins against beta-lactamase producing Staphylococcus aureus. Indian J Med Res 1984; 79: 482-6.
11. Mathai D, Rhomberg PR, Biedenbach DJ, Jones RN. The Indian Antimicrobial Resistance Study Group. Evaluation of the in vitro activity of six broad-spectrum -beta-lactam antimicrobial agents tested against recent clinical isolates from India: a survey of ten medical center laboratories. Diagn Microbiol Infect Dis 2002; 44: 367-77.
12. Chitnis S, Chitnis V, Hemavani N, Chitnis DS. In vitro susceptibility to merepenem and other antimicrobial agents among Gram-negative bacilli isolated from hospitalized patients in central India. Chemotherapy 2006; 52 43-5.
13. Gupta E, Mohanty S, Sood S, Dhawan B, Das BK, Kapil A. Emerging resistance to carbapenem in a tertiary care hospital in north India. Indian J Med Res 2006; 124: 95-8.